336
Cavalli R, Trotta F, Carlotti ME, Possetti B, Trotta M (2007) Nanoparticles derived from
amphiphilic-γ-cyclodextrins. J Incl Phenom Macrocycl Chem 57:657–661. https://doi.
org/10.1007/s10847-006-9269-9
Challa R, Ahuja A, Ali J, Khar RK (2005) Cyclodextrins in drug delivery: an updated review.
AAPS Pharm SciTech 6:2. https://doi.org/10.1208/pt060243
Chen H, Gao J, Wang F, Wenquan L (2007) Preparation, characterization and pharmacokinetics of
liposomes-encapsulated cyclodextrins inclusion complexes for hydrophobic drugs. Drug Deliv
14:201–208. https://doi.org/10.1080/10717540601036880
Chen P, Song H, Yao S, Tu X, Su M, Zhou L (2017) Magnetic targeted nanoparticles based on
β-cyclodextrin and chitosan for hydrophobic drug delivery and a study of their mechanism.
RSC Adv 7:29025–29034. https://doi.org/10.1039/C7RA02398G
Chen P, Yao S, Chen X, Huang Y, Song H (2019) A new strategy for the construction of
β-cyclodextrin-based magnetic nanocarriers: a molecular docking technique. New J Chem
43:4282–4290. https://doi.org/10.1039/c8nj06131a
Chirio D, Gallarate M, Peira E, Battaglia L, Serpe L, Trotta M (2011) Formulation of curcuminloaded solid lipid nanoparticles produced by fatty acids coacervation technique. J Microencapsul
28:537–548. https://doi.org/10.3109/02652048.2011.590615
Çirpanli Y, Bilensoy E, Lale Doǧan A, Çaliş S (2009) Comparative evaluation of polymeric and
amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery. Eur J Pharm
Biopharm 73:82–89. https://doi.org/10.1016/j.ejpb.2009.04.013
Çirpanli Y, Allard E, Passirani C, Bilensoy E, Lemaire L, Caliş S, Benoit JP (2011) Antitumoral
activity of camptothecin-loaded nanoparticles in 9L rat glioma model. Int J Pharm 17:201–206.
https://doi.org/10.1016/j.ijpharm.2010.10.015
Cirri M, Bragagni M, Mennini N, Mura P (2012) Development of a new delivery system consisting
in “drug – In cyclodextrin – In nanostructured lipid carriers” for ketoprofen topical delivery.
Eur J Pharm Biopharm 80:46–53. https://doi.org/10.1016/j.ejpb.2011.07.015
Cirri M, Mennini N, Maestrelli F, Mura P, Ghelardini Cyclodextrini Cesare Mannelli L (2017)
Development and in vivo evaluation of an innovative “hydrochlorothiazide-in cyclodextrinsin solid lipid nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics. Int J Pharm 521:73–83. https://doi.
org/10.1016/j.ijpharm.2017.02.022
Cirri M, Maestrelli F, Mura P, Ghelardini C, Mannelli LDC (2018) Combined approach of cyclodextrin complexation and nanostructured lipid carriers for the development of a pediatric liquid oral dosage form of hydrochlorothiazide. Pharmaceutics 10:287. https://doi.org/10.3390/
pharmaceutics10040287
Conte C, Costabile G, d’Angelo I, Pannico M, Musto P, Grassia G, Ialenti A, Tirino P, Miro A,
Ungaro F, Quaglia F (2015) Skin transport of PEGylated poly(ε-caprolactone) nanoparticles
assisted by (2-hydroxypropyl)-β-cyclodextrin. J Colloid Interface Sci 454:112–120. https://doi.
org/10.1016/j.jcis.2015.05.010
Crini G (2014) Review: a history of cyclodextrins. Chem Rev 114:10940–10975. https://doi.
org/10.1021/cr500081p
Da Silveira AM, Ponchel G, Puisieux F, Duchêne D (1998) Combined poly(isobutylcyanoacrylate)
and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs. Pharm Res
15:1051–1055. https://doi.org/10.1023/A:1011982211632
Datz S, Illes B, Gößl D, Schirnding CV, Engelke H, Bein T (2018) Biocompatible crosslinked
β-cyclodextrin nanoparticles as multifunctional carriers for cellular delivery. Nanoscale
10:16284–16292. https://doi.org/10.1039/c8nr02462f
Dhule SS, Penfornis P, Frazier T, Walker R, Feldman J, Tan G, He J, Alb A, John V, Pochampally R
(2012) Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine 8:440–451. https://doi.org/10.1016/j.nano.2011.07.011
Díaz-Moscoso A, Guilloteau N, Bienvenu C, Méndez-Ardoy A, Jiménez Blanco J, Benito
J, Gourriérec L, Di Giorgio C, Vierling P, Defaye J, Mellet C, García Fernández J (2011)
A. Pandey
Cavalli R, Trotta F, Carlotti ME, Possetti B, Trotta M (2007) Nanoparticles derived from
amphiphilic-γ-cyclodextrins. J Incl Phenom Macrocycl Chem 57:657–661. https://doi.
org/10.1007/s10847-006-9269-9
Challa R, Ahuja A, Ali J, Khar RK (2005) Cyclodextrins in drug delivery: an updated review.
AAPS Pharm SciTech 6:2. https://doi.org/10.1208/pt060243
Chen H, Gao J, Wang F, Wenquan L (2007) Preparation, characterization and pharmacokinetics of
liposomes-encapsulated cyclodextrins inclusion complexes for hydrophobic drugs. Drug Deliv
14:201–208. https://doi.org/10.1080/10717540601036880
Chen P, Song H, Yao S, Tu X, Su M, Zhou L (2017) Magnetic targeted nanoparticles based on
β-cyclodextrin and chitosan for hydrophobic drug delivery and a study of their mechanism.
RSC Adv 7:29025–29034. https://doi.org/10.1039/C7RA02398G
Chen P, Yao S, Chen X, Huang Y, Song H (2019) A new strategy for the construction of
β-cyclodextrin-based magnetic nanocarriers: a molecular docking technique. New J Chem
43:4282–4290. https://doi.org/10.1039/c8nj06131a
Chirio D, Gallarate M, Peira E, Battaglia L, Serpe L, Trotta M (2011) Formulation of curcuminloaded solid lipid nanoparticles produced by fatty acids coacervation technique. J Microencapsul
28:537–548. https://doi.org/10.3109/02652048.2011.590615
Çirpanli Y, Bilensoy E, Lale Doǧan A, Çaliş S (2009) Comparative evaluation of polymeric and
amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery. Eur J Pharm
Biopharm 73:82–89. https://doi.org/10.1016/j.ejpb.2009.04.013
Çirpanli Y, Allard E, Passirani C, Bilensoy E, Lemaire L, Caliş S, Benoit JP (2011) Antitumoral
activity of camptothecin-loaded nanoparticles in 9L rat glioma model. Int J Pharm 17:201–206.
https://doi.org/10.1016/j.ijpharm.2010.10.015
Cirri M, Bragagni M, Mennini N, Mura P (2012) Development of a new delivery system consisting
in “drug – In cyclodextrin – In nanostructured lipid carriers” for ketoprofen topical delivery.
Eur J Pharm Biopharm 80:46–53. https://doi.org/10.1016/j.ejpb.2011.07.015
Cirri M, Mennini N, Maestrelli F, Mura P, Ghelardini Cyclodextrini Cesare Mannelli L (2017)
Development and in vivo evaluation of an innovative “hydrochlorothiazide-in cyclodextrinsin solid lipid nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics. Int J Pharm 521:73–83. https://doi.
org/10.1016/j.ijpharm.2017.02.022
Cirri M, Maestrelli F, Mura P, Ghelardini C, Mannelli LDC (2018) Combined approach of cyclodextrin complexation and nanostructured lipid carriers for the development of a pediatric liquid oral dosage form of hydrochlorothiazide. Pharmaceutics 10:287. https://doi.org/10.3390/
pharmaceutics10040287
Conte C, Costabile G, d’Angelo I, Pannico M, Musto P, Grassia G, Ialenti A, Tirino P, Miro A,
Ungaro F, Quaglia F (2015) Skin transport of PEGylated poly(ε-caprolactone) nanoparticles
assisted by (2-hydroxypropyl)-β-cyclodextrin. J Colloid Interface Sci 454:112–120. https://doi.
org/10.1016/j.jcis.2015.05.010
Crini G (2014) Review: a history of cyclodextrins. Chem Rev 114:10940–10975. https://doi.
org/10.1021/cr500081p
Da Silveira AM, Ponchel G, Puisieux F, Duchêne D (1998) Combined poly(isobutylcyanoacrylate)
and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs. Pharm Res
15:1051–1055. https://doi.org/10.1023/A:1011982211632
Datz S, Illes B, Gößl D, Schirnding CV, Engelke H, Bein T (2018) Biocompatible crosslinked
β-cyclodextrin nanoparticles as multifunctional carriers for cellular delivery. Nanoscale
10:16284–16292. https://doi.org/10.1039/c8nr02462f
Dhule SS, Penfornis P, Frazier T, Walker R, Feldman J, Tan G, He J, Alb A, John V, Pochampally R
(2012) Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine 8:440–451. https://doi.org/10.1016/j.nano.2011.07.011
Díaz-Moscoso A, Guilloteau N, Bienvenu C, Méndez-Ardoy A, Jiménez Blanco J, Benito
J, Gourriérec L, Di Giorgio C, Vierling P, Defaye J, Mellet C, García Fernández J (2011)
A. Pandey